Sabra Health Care REIT (SBRA) Cash from Financing Activities (2011 - 2026)

Sabra Health Care REIT's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $52.1 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 151.46% year-over-year to $52.1 million; the TTM figure through Mar 2026 stood at $194.1 million (up 173.92% YoY), while the FY2025 annual figure was $40.8 million, up 122.45% from the prior year.
• Cash from Financing Activities was $52.1 million for Q1 2026 at Sabra Health Care REIT, up from -$100.9 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $206.2 million in Q3 2025 to a low of -$196.1 million in Q1 2023.
• Historically, Cash from Financing Activities has averaged -$38.9 million across 5 years, with a median of -$46.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities surged 2164.31% in 2022, then plunged 978.33% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$13.5 million in 2022, then soared by 30.74% to -$9.4 million in 2023, then slumped by 978.33% to -$101.0 million in 2024, then grew by 0.07% to -$100.9 million in 2025, then surged by 151.64% to $52.1 million in 2026.
• The last three Cash from Financing Activities figures came in at $52.1 million (Q1 2026), -$100.9 million (Q4 2025), and $206.2 million (Q3 2025), per Business Quant data.